CrystarVision to lead Project ARGOS — a national AI demonstration for chronic disease management with regional and partner public institutions in Gangwon-do and Gyeonggi-do, Korea
We're proud to share that CrystarVision has been selected as the lead organization for a national demonstration project under the AI Applied Product Rapid Commercialization Support Program, driven by Korea's Ministry of Health and Welfare (MOHW) and the Korea Health Industry Development Institute (KHIDI) — an initiative we've named Project ARGOS.
At the kickoff meeting held on June 25 at the Wonju Medical Industry Institute of Technology (WMIT), our consortium came together to launch a demonstration centered on AI-based chronic disease management across public healthcare institutions in the Gangwon region, together with Seongnam Citizens Medical Center in Gyeonggi-do.
Ophthalmology is at the core of this project. Chronic eye conditions — such as diabetic retinopathy, age-related macular degeneration, and glaucoma — require continuous monitoring, yet regular follow-up is often difficult in areas with limited access to specialized eye care. Project ARGOS aims to build and validate AI-powered ophthalmic chronic disease management models in real-world clinical settings, and to develop models that can scale to other public medical institutions.
Consortium partners: INFINITT Healthcare, Kangwon National University Hospital, Gangwon Yeongwol Medical Center, Gangwon Gangneung Medical Center, Pyeongchang County Health & Medical Center, Seongnam Citizens Medical Center, Heuron, and Walk1o1.
CrystarVision brings Reticare, an AI diagnostic-support solution that screens major ophthalmic diseases — such as diabetic retinopathy, age-related macular degeneration, Epiretinal Membrane , Retinal vein occlusion and glaucoma suspect — from fundus images. Reticare is designated as an MFDS Innovative Medical Device (Integrated No. 128) and integrates naturally into clinical workflows through PACS·EMR linkage.
"Project ARGOS is a meaningful demonstration where public medical institutions and companies in Gangwon come together with government support. We will work closely with our partners to build an AI healthcare service model that makes a real difference in regional care."
— Sujeong Song, CEO, CrystarVision
\
#DigitalHealth #MedicalAI #Ophthalmology #ChronicDiseaseManagement #HealthcareInnovation #PublicHealth #CrystarVision #ProjectARGOS #AIinHealthcare